Patient Guide: A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 17 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06508320
Status: ACTIVE_NOT_RECRUITING
Condition: Influenza, SARS-CoV-2
Phase: PHASE2

Where You Can Participate

This study is available at 17 locations across the country.

Top locations include:
  • • Hialeah, Florida
  • • Hollywood, Florida
  • • Miami, Florida
  • • And 14 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine) - Join Clinical Trial NCTNCT06508320

How to Join This Clinical Trial - NCTNCT06508320

Learn how to participate in this PHASE2 trial studying an investigational therapy for Influenza, SARS-CoV-2. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Influenza, SARS-CoV-2. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Influenza, SARS-CoV-2
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06508320 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 17 locations. Find a study site near you:

Clinical Research Site

Hialeah, Florida 33012 - United States

Status: Contact for availability

Clinical Research Site

Hollywood, Florida 33024 - United States

Status: Contact for availability

Clinical Research Site

Miami, Florida 33135 - United States

Status: Contact for availability

Clinical Research Site

Decatur, Georgia 30030 - United States

Status: Contact for availability

Clinical Research Site

River Forest, Illinois 60305 - United States

Status: Contact for availability

Clinical Research Site

Lenexa, Kansas 66219 - United States

Status: Contact for availability

Clinical Research Site

Marlton, New Jersey 80530 - United States

Status: Contact for availability

Clinical Research Site

Philadelphia, Pennsylvania 19107 - United States

Status: Contact for availability

Clinical Research Site

Houston, Texas 77065-5685 - United States

Status: Contact for availability

Clinical Research Site

San Antonio, Texas 78229 - United States

Status: Contact for availability

And 7 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Influenza, SARS-CoV-2:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships